Eliana Abdelhay

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 19

Top Topics

Positive Breast Cancer

Sentinel Lymph Node

Network Analysis

Chronic Myeloid Leukemia

Top Venues

International journal of molecular sciences

Annals of translational medicine

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Paula D Alves, Paulo Rohan, Rocio Hassan, Eliana Abdelhay
Lytic and Latent Genetic Diversity of the Epstein-Barr Virus Reveals Raji-Related Variants from Southeastern Brazil Associated with Recombination Markers. International journal of molecular sciences 25 (9) (2024)
Bruno Henrique Rala de Paula, Eliana Abdelhay, Carlos Augusto Moreira de Sousa, Susanne Crocamo Ventilari da Costa
Survival outcomes of Zo-NAnTAx: a five-year analysis of zoledronic acid added to a neoadjuvant regimen for HER2-positive breast cancer. Annals of translational medicine 12 (3) (2024)
Bruno de Paula, Susanne Crocamo, Carlos Augusto Moreira de Sousa, Priscila Valverde, Fabiana Rezende, Eliana Abdelhay
Triple-Negative Breast Cancer Subclassified by Immunohistochemistry: Correlation with Clinical and Pathological Outcomes in Patients Receiving Neoadjuvant Chemotherapy. International journal of molecular sciences 25 (11) (2024)
Paula D Alves, Paulo Rohan, Rocio Hassan, Eliana Abdelhay
Lytic and Latent Genetic Diversity of the Epstein-Barr Virus Reveals Raji-Related Variants from Southeastern Brazil Associated with Recombination Markers. International journal of molecular sciences 25 (9) (2024)
Bruno de Paula, Susanne Crocamo, Carlos Augusto Moreira de Sousa, Priscila Valverde, Fabiana Rezende, Eliana Abdelhay
Triple-Negative Breast Cancer Subclassified by Immunohistochemistry: Correlation with Clinical and Pathological Outcomes in Patients Receiving Neoadjuvant Chemotherapy. International journal of molecular sciences 25 (11) (2024)
Bruno Henrique Rala de Paula, Eliana Abdelhay, Carlos Augusto Moreira de Sousa, Susanne Crocamo Ventilari da Costa
Survival outcomes of Zo-NAnTAx: a five-year analysis of zoledronic acid added to a neoadjuvant regimen for HER2-positive breast cancer. Annals of translational medicine 12 (3) (2024)
Paulo Rohan, Everton Cruz Dos Santos, Eliana Abdelhay, Renata Binato
High Expression of THY1 in Intestinal Gastric Cancer as a Key Factor in Tumor Biology: A Poor Prognosis-Independent Marker Related to the Epithelial-Mesenchymal Transition Profile. Genes 15 (1) (2023)
Everton Cruz Dos Santos, Paulo Rohan, Renata Binato, Eliana Abdelhay
Integrated Network Analysis of microRNAs, mRNAs, and Proteins Reveals the Regulatory Interaction between hsa-mir-200b and CFL2 Associated with Advanced Stage and Poor Prognosis in Patients with Intestinal Gastric Cancer. Cancers 15 (22) (2023)
Paulo Rohan, Everton Cruz Dos Santos, Eliana Abdelhay, Renata Binato
High Expression of THY1 in Intestinal Gastric Cancer as a Key Factor in Tumor Biology: A Poor Prognosis-Independent Marker Related to the Epithelial-Mesenchymal Transition Profile. Genes 15 (1) (2023)
Paulo Rohan, Everton Cruz Dos Santos, Eliana Abdelhay, Renata Binato
High Expression of THY1 in Intestinal Gastric Cancer as a Key Factor in Tumor Biology: A Poor Prognosis-Independent Marker Related to the Epithelial-Mesenchymal Transition Profile. Genes 15 (1) (2023)
Paulo Rohan, Everton Cruz Dos Santos, Eliana Abdelhay, Renata Binato
High Expression of THY1 in Intestinal Gastric Cancer as a Key Factor in Tumor Biology: A Poor Prognosis-Independent Marker Related to the Epithelial-Mesenchymal Transition Profile. Genes 15 (1) (2023)
Paulo Rohan, Everton Cruz Dos Santos, Eliana Abdelhay, Renata Binato
High Expression of THY1 in Intestinal Gastric Cancer as a Key Factor in Tumor Biology: A Poor Prognosis-Independent Marker Related to the Epithelial-Mesenchymal Transition Profile. Genes 15 (1) (2023)
Bruno Henrique Rala de Paula, Rosalind Kieran, Samantha Shui Yuan Koh, Susanne Crocamo Ventilari da Costa, Eliana Abdelhay, Daniel Muñoz-Espín
Targeting senescence as a therapeutic opportunity for triple-negative breast cancer. Molecular cancer therapeutics (2023)
Roberto R Capela de Matos, Gerson Moura Ferreira, Simone Bonecker, Mainá Rouxinol, Elaine Sobral da Costa, Fabiana V Mello, Eliana Abdelhay, Raul C Ribeiro, Ilana Zalcberg, Maria Luiza Macedo Silva
BCR - ABL1 co-occurring with CBFA2T3 - GLIS2 and RAM immunophenotype in a non-Down syndrome infant with acute megakaryoblastic leukemia. Leukemia & lymphoma (2023)
Igor Petrone, Everton Cruz Dos Santos, Renata Binato, Eliana Abdelhay
Epigenetic Alterations in DCIS Progression: What Can lncRNAs Teach Us? International journal of molecular sciences 24 (10) (2023)
Viviane Lamim Lovatel, Eliane Ferreira Rodrigues, Beatriz Ferreira da Silva, Cecilia de Souza Fernandez, Elaine Sobral da Costa, Eliana Abdelhay, Sheila Coelho Soares Lima, Teresa de Souza Fernandez Seixas
Global methylation status of LINE-1 in pediatric myelodysplastic syndrome: a predictive biomarker of prognosis? Leukemia & lymphoma (2022)
Igor Petrone, Paula Sabbo Bernardo, Everton Cruz Dos Santos, Eliana Abdelhay
MTHFR C677T and A1298C Polymorphisms in Breast Cancer, Gliomas and Gastric Cancer: A Review. Genes 12 (4) (2021)
Viviane Lamim Lovatel, Cecilia de Souza Fernandez, Eliane Ferreira Rodrigues, Rita de Cássia Barbosa Tavares, Elaine Sobral da Costa, Eliana Abdelhay, Sheila Coelho Soares Lima, Teresa de Souza Fernandez Seixas
Expression Profiles of DNA Methylation and Demethylation Machinery Components in Pediatric Myelodysplastic Syndrome: Clinical Implications. Cancer management and research 12 (2020)
Teresa de Souza Fernandez Seixas, Tatiana Fonseca Alvarenga, Elaiza Almeida Antônio de Kós, Viviane Lamim Lovatel, Rita de Cássia Tavares, Elaine Sobral da Costa, Cecília de Souza Fernandez, Eliana Abdelhay
Aberrant Expression of EZH2 in Pediatric Patients with Myelodysplastic Syndrome: A Potential Biomarker of Leukemic Evolution. BioMed research international 2019 (2019)